FDA Policy In Biosimilars, “Breakthrough” And Social Media Under New Management
This article was originally published in The Pink Sheet Daily
Executive Summary
Office of Medical Policy’s leadership gets reshuffled following retirement of the long-time CDER denizen Rachel Sherman.